194 related articles for article (PubMed ID: 26206763)
1. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010.
Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
Nephrol Dial Transplant; 2016 Apr; 31(4):595-602. PubMed ID: 26206763
[TBL] [Abstract][Full Text] [Related]
2. Carpal tunnel surgery as proxy for dialysis-related amyloidosis: results from the Japanese society for dialysis therapy.
Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
Am J Nephrol; 2014; 39(5):449-58. PubMed ID: 24819459
[TBL] [Abstract][Full Text] [Related]
3. Dialysis-related carpal tunnel syndrome in the past 40 years.
Hatano M; Kitajima I; Yamamoto S; Nakamura M; Isawa K; Suwabe T; Hoshino J; Sawa N; Ubara Y
Clin Exp Nephrol; 2022 Jan; 26(1):68-74. PubMed ID: 34415463
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological survey and risk factor analysis of dialysis-related amyloidosis including destructive spondyloarthropathy, dialysis amyloid arthropathy, and carpal tunnel syndrome.
Tagami A; Tomita M; Adachi S; Tsuda K; Yamada S; Chiba K; Okazaki N; Yonekura A; Tsujimoto R; Kajiyama S; Matsubayashi S; Miyamoto T; Mochizuki Y; Ohba K; Osaki M
J Bone Miner Metab; 2020 Jan; 38(1):78-85. PubMed ID: 31414282
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of dialysis-related amyloidosis: focusing on carpal tunnel syndrome].
Nishi S
Brain Nerve; 2014 Jul; 66(7):783-93. PubMed ID: 24998823
[TBL] [Abstract][Full Text] [Related]
6. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
Schiffl H
Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto.
Locatelli F; Marcelli D; Conte F; Limido A; Malberti F; Spotti D
Kidney Int; 1999 Jan; 55(1):286-93. PubMed ID: 9893138
[TBL] [Abstract][Full Text] [Related]
8. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
Saito A; Gejyo F
Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
[TBL] [Abstract][Full Text] [Related]
9. Carpal tunnel syndrome in hemodialysis patients as a dialysis-related amyloidosis manifestation--incidence, risk factors and results of surgical treatment.
Kopeć J; Gadek A; Drozdz M; Miśkowiec K; Dutka J; Sydor A; Chowaniec E; Sułowicz W
Med Sci Monit; 2011 Sep; 17(9):CR505-9. PubMed ID: 21873947
[TBL] [Abstract][Full Text] [Related]
10. beta2-microglobulin-derived amyloidosis: an update.
Floege J; Ketteler M
Kidney Int Suppl; 2001 Feb; 78():S164-71. PubMed ID: 11169004
[TBL] [Abstract][Full Text] [Related]
11. Hemodialysis-related amyloidosis: Is it still relevant?
Kaneko S; Yamagata K
Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
[TBL] [Abstract][Full Text] [Related]
12. Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients.
Motomiya Y; Ando Y; Haraoka K; Sun X; Iwamoto H; Uchimura T; Maruyama I
Kidney Int; 2003 Dec; 64(6):2244-52. PubMed ID: 14633149
[TBL] [Abstract][Full Text] [Related]
13. Multicentre cross-sectional study for bone-articular lesions associated with dialysis related amyloidosis in Japan.
Nishi S; Hoshino J; Yamamoto S; Goto S; Fujii H; Ubara Y; Motomiya Y; Morita H; Takaichi K; Yamagata K; Shigematsu T; Ueda M; Ando Y
Nephrology (Carlton); 2018 Jul; 23(7):640-645. PubMed ID: 28556529
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
15. Carpal tunnel syndrome and plasma beta2-microglobulin concentration in hemodialysis patients.
Shin J; Nishioka M; Shinko S; Shibuya K; Sugiki M; Kasumoto H; Fudo A; Bito Y; Fujita Y; Komaba K
Ther Apher Dial; 2008 Feb; 12(1):62-6. PubMed ID: 18257814
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients.
Busch M; Schwenzky A; Franke S; Stein G; Wolf G
Blood Purif; 2012; 34(1):3-9. PubMed ID: 22699860
[TBL] [Abstract][Full Text] [Related]
17. Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach.
Cianciolo G; Colí L; La Manna G; Donati G; D'Addio F; Comai G; Ricci D; Dormi A; Wratten M; Feliciangeli G; Stefoni S
Int J Artif Organs; 2007 Oct; 30(10):864-78. PubMed ID: 17992647
[TBL] [Abstract][Full Text] [Related]
18. Carpal tunnel syndrome and beta 2-microglobulin-related amyloidosis in chronic hemodialysis patients.
Gejyo F; Homma N; Arakawa M
Blood Purif; 1988; 6(2):125-31. PubMed ID: 3293616
[No Abstract] [Full Text] [Related]
19. The relationship between pentosidine and hemodialysis-related connective tissue disorders.
Sakata S; Takahashi M; Kushida K; Oikawa M; Hoshino H; Denda M; Inoue T
Nephron; 1998; 78(3):260-5. PubMed ID: 9546683
[TBL] [Abstract][Full Text] [Related]
20. [Kidney and bone update : the 5-year history and future of CKD-MBD. Treatment for dialysis-related amyloidosis update].
Yamamoto S; Kazama JJ; Narita I
Clin Calcium; 2012 Jul; 22(7):1089-98. PubMed ID: 22750942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
